NCT04500145 2021-02-01
Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer
ChineseAMS
Phase 3 Unknown
Clinical Trials
7 trialsNCT04683198 2020-12-24
Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC
ChineseAMS
Phase 2 Unknown
NCT04620837 2020-11-09
Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy
ChineseAMS
Phase 2 Unknown
NCT04535739 2020-09-02
PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study
ChineseAMS
Phase 3 Unknown
NCT03971214 2019-06-04
PICARES
ChineseAMS
Phase 1 Unknown
NCT02995187 2017-09-07
Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)
ChineseAMS
Phase 2 Unknown
NCT02323737 2014-12-30
Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer
ChineseAMS
Phase 2 Completed